Search

Your search keyword '"Nikolaus, Susanna"' showing total 374 results

Search Constraints

Start Over You searched for: Author "Nikolaus, Susanna" Remove constraint Author: "Nikolaus, Susanna"
374 results on '"Nikolaus, Susanna"'

Search Results

1. Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn’s disease

2. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

3. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

4. Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease

5. DNA methyltransferase 3A controls intestinal epithelial barrier function and regeneration in the colon

6. Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis

7. Association Between Variants of PRDM1 and NDP52 and Crohn's Disease, Based on Exome Sequencing and Functional Studies

10. Stark reduzierte Impftiter nach mRNA SARS-CoV-2 Impfung bei Patienten unter TNF-Blocker Therapie

11. Interobserver Reliability of the Nancy Index for Ulcerative Colitis: An Assessment of the Practicability and Ease of Use in a Single-Centre Real-World Setting

12. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease

13. Distinct Longitudinal Changes in Immunoglobulin G N-Glycosylation Associate with Therapy Response in Chronic Inflammatory Diseases

14. Su1553: THE ROAD TO DISEASE CONTROL: COMBINATION OF HISTOLOGIC AND ENDOSCOPIC REMISSION PREDICTS LONG-TERM DISEASE OUTCOME IN ULCERATIVE COLITIS

15. Mo1517: LONGITUDINAL MULTI-OMICS ANALYSIS IDENTIFIES EARLY BLOODBASED PREDICTORS OF ANTI-TNF THERAPY RESPONSE IN INFLAMMATORY BOWEL DISEASE

16. Mo1083: ON THE WAY TO DISEASE CONTROL: FATIGUE AS PART OF A NOVEL COMPOSITE ENDPOINT IN AN ANALYSIS OF A PROSPECTIVE OPEN LABEL OBSERVATION TRIAL

18. Detailed transcriptional landscape of peripheral blood points to increased neutrophil activation in treatment-naïve inflammatory bowel disease

19. Interobserver Reliability of the Nancy Index for Ulcerative Colitis: An Assessment of the Practicability and Ease of Use in a Single-Centre Real-World Setting.

22. Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis

23. Additional file 2 of Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease

25. Genome-Wide Association Study for Crohn's Disease in the Quebec Founder Population Identifies Multiple Validated Disease Loci

26. Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies

28. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

34. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases

37. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease

39. A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology

41. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

44. Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NETIBD)

45. Genetic Variation in the CYP2C Monooxygenase Enzyme Subfamily Shows No Association With Longevity in a German Population

47. Reply

48. Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

49. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases

50. Mucus Detachment by Host Metalloprotease Meprin β Requires Shedding of Its Inactive Pro-form, which Is Abrogated by the Pathogenic Protease RgpB

Catalog

Books, media, physical & digital resources